- Home
- CRGX vs TGB Comparison
CRGX vs TGB Comparison
Compare CRGX & TGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGX
- TGB
- Stock Information
- Founded
- CRGX 2021
- TGB 1966
- Country
- CRGX United States
- TGB Canada
- Employees
- CRGX N/A
- TGB N/A
- Industry
- CRGX
- TGB Precious Metals
- Sector
- CRGX
- TGB Basic Materials
- Exchange
- CRGX Nasdaq
- TGB Nasdaq
- Market Cap
- CRGX 190.0M
- TGB 698.1M
- IPO Year
- CRGX 2023
- TGB N/A
- Fundamental
- Price
- CRGX $4.16
- TGB $3.05
- Analyst Decision
- CRGX Hold
- TGB
- Analyst Count
- CRGX 7
- TGB 0
- Target Price
- CRGX $4.67
- TGB N/A
- AVG Volume (30 Days)
- CRGX 586.4K
- TGB 15.0M
- Earning Date
- CRGX 08-11-2025
- TGB 07-30-2025
- Dividend Yield
- CRGX N/A
- TGB N/A
- EPS Growth
- CRGX N/A
- TGB N/A
- EPS
- CRGX N/A
- TGB N/A
- Revenue
- CRGX N/A
- TGB $417,640,101.00
- Revenue This Year
- CRGX $57.81
- TGB $22.13
- Revenue Next Year
- CRGX N/A
- TGB $36.13
- P/E Ratio
- CRGX N/A
- TGB N/A
- Revenue Growth
- CRGX N/A
- TGB 7.89
- 52 Week Low
- CRGX $3.00
- TGB $1.67
- 52 Week High
- CRGX $25.45
- TGB $3.17
- Technical
- Relative Strength Index (RSI)
- CRGX 45.07
- TGB 69.43
- Support Level
- CRGX $4.33
- TGB $2.83
- Resistance Level
- CRGX $4.36
- TGB $3.02
- Average True Range (ATR)
- CRGX 0.19
- TGB 0.15
- MACD
- CRGX -0.04
- TGB -0.00
- Stochastic Oscillator
- CRGX 21.76
- TGB 98.91
About CRGX CARGO Therapeutics Inc.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.
About TGB Taseko Mines Ltd.
Taseko Mines Ltd is a Canadian mining company. It is principally engaged in the production and sale of metals, as well as related activities, including exploration and mine development, within the province of British Columbia, Canada, and the State of Arizona, the United States. The Gibraltar, Aley, New Prosperity, Yellowhead properties are located in British Columbia whereas Florence copper is in central Arizona.